Recombinant multi-species SIGMAR1/OPRS1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SIGMAR1/OPRS1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a receptor protein that interacts with a variety of psychotomimetic drugs, including cocaine and amphetamines. The receptor is believed to play an important role in the cellular functions of various tissues associated with the endocrine, immune, and nervous systems. As indicated by its previous name, opioid receptor sigma 1 (OPRS1), the product of this gene was erroneously thought to function as an opioid receptor; it is now thought to be a non-opioid receptor. Mutations in this gene has been associated with juvenile amyotrophic lateral sclerosis 16. Alternative splicing of this gene results in transcript variants encoding distinct isoforms. [provided by RefSeq, Aug 2013]
The Alternative Names of target: ALS16,Aging-associated gene 8 protein,DSMA2,HMNR2,OPRS1,Oprs1,SIG-1R,SIGMAR1,SR-BP,SR-BP1,SR31747-binding protein (SR-BP),SRBP,Sig1R,Sigma 1-type opioid receptor (SIG-1R,Sigma non-opioid intracellular receptor 1,Sigma1-receptor,Sigma1R,Sigmar1,hSigmaR1,hSigmaR1),sigma1R

Target products collectionGo to SIGMAR1/OPRS1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0013-Ag-1/ GM-Tg-hg-IP0013-Ag-2 Human SIGMAR1/OPRS1 protein Human
GM-Tg-rg-IP0013-Ag-1/ GM-Tg-rg-IP0013-Ag-2 Rat SIGMAR1/OPRS1 protein Rat
GM-Tg-mg-IP0013-Ag-1/ GM-Tg-mg-IP0013-Ag-2 Mouse SIGMAR1/OPRS1 protein Mouse
GM-Tg-cynog-IP0013-Ag-1/ GM-Tg-cynog-IP0013-Ag-2 Cynomolgus/Rhesus macaque SIGMAR1/OPRS1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0013-Ag-1/ GM-Tg-felg-IP0013-Ag-2 Feline SIGMAR1/OPRS1 protein Feline
GM-Tg-cang-IP0013-Ag-1/ GM-Tg-cang-IP0013-Ag-2 Canine SIGMAR1/OPRS1 protein Canine
GM-Tg-bovg-IP0013-Ag-1/ GM-Tg-bovg-IP0013-Ag-2 Bovine SIGMAR1/OPRS1 protein Bovine
GM-Tg-equg-IP0013-Ag-1/ GM-Tg-equg-IP0013-Ag-2 Equine SIGMAR1/OPRS1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0013-Ag-1/ GM-Tg-hg-IP0013-Ag-2; GM-Tg-rg-IP0013-Ag-1/ GM-Tg-rg-IP0013-Ag-2;
GM-Tg-mg-IP0013-Ag-1/ GM-Tg-mg-IP0013-Ag-2; GM-Tg-cynog-IP0013-Ag-1/ GM-Tg-cynog-IP0013-Ag-2;
GM-Tg-felg-IP0013-Ag-1/ GM-Tg-felg-IP0013-Ag-2; GM-Tg-cang-IP0013-Ag-1/ GM-Tg-cang-IP0013-Ag-2;
GM-Tg-bovg-IP0013-Ag-1/ GM-Tg-bovg-IP0013-Ag-2; GM-Tg-equg-IP0013-Ag-1/ GM-Tg-equg-IP0013-Ag-2
Products Name SIGMAR1/OPRS1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SIGMAR1/OPRS1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SIGMAR1/OPRS1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.